Reni Benjamin Analyst PerformanceAnalyst at Citizens JmpReni Benjamin is a stock analyst at Citizens Jmp focused in the healthcare sector, covering 48 publicly traded companies. Over the past year, Reni Benjamin has issued 37 stock ratings, including buy and hold recommendations. While full access to Reni Benjamin's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Reni Benjamin's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings203 Last 12 YearsBuy Recommendations80.81% 160 Buy RatingsCompanies Covered48 Unique Companies Ratings Distribution198RatingsDistribution of strong buy, buy, hold, and sell ratings by Reni Benjamin.RatingPercentageCount Strong Buy0.5%1 ratings Buy80.3%159 ratings Hold18.7%37 ratings Sell0.5%1 ratingsOut of 198 total stock ratings issued by Reni Benjamin at Citizens Jmp, the majority (80.3%) have been Buy recommendations, followed by 18.7% Hold, 0.5% Strong Buy, and 0.5% Sell.Best & Worst CallsBest Call0000.0%PRLDAug 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%EFTRMar 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ87.5% of companies on NASDAQ42 companiesNYSE8.3% of companies on NYSE4 companiesNYSEAMERICAN2.1% of companies on NYSEAMERICAN1 companyOTCMKTS2.1% of companies on OTCMKTS1 companyReni Benjamin, an analyst at Citizens Jmp, currently covers 48 companies listed on NASDAQ, NYSE, NYSEAMERICAN and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare44 companies91.7%Industrials1 company2.1%Finance1 company2.1%Technology1 company2.1%Miscellaneous1 company2.1%Reni Benjamin of Citizens Jmp specializes in stock coverage within the Healthcare sector, with additional focus on Industrials and Finance companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY37 companies77.1%PHARMACEUTICALS6 companies12.5%GROUND TRANSPORTATION1 company2.1%HEALTHCARE EQUIPMENT & SUPPLIES1 company2.1%FINANCIAL SERVICES1 company2.1%SOFTWARE1 company2.1%Miscellaneous1 company2.1% About Reni BenjaminDr. Reni J. Benjamin is an Equity Research Analyst at Citizens JMP Securities LLC. He is on the Board of Directors at Centre For Commercialization of Regenerative Medicine. He is covering biotechnology. He currently serves on the advisory board of Phacilitate Cell & Gene Therapy. Dr. Benjamin joins JMP Securities from Raymond James, where he was a managing director and senior research analyst. Dr. Benjamin was previously a managing director at H.C. Wainwright & Co. and Rodman & Renshaw, after starting his career in biotechnology research at Needham & Company. He is a past member of the UAB School of Health Professions Dean's Advisory Board. Dr. Benjamin holds a Ph.D. in biochemistry and molecular genetics from the University of Alabama at Birmingham and a B.S. in biology from Allegheny College.Follow on LinkedIn Reni Benjamin's Ratings History at Citizens Jmp Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsZYMEZymeworks8/26/2026Reiterated Rating$27.47$32.00Market Outperform$0.0000.00% ROIKURAKura Oncology8/24/2026Reiterated Rating$11.89$24.00Market Outperform$0.0000.00% ROIALLOAllogene Therapeutics8/17/2026Reiterated Rating$2.05$6.00Market Outperform$0.0000.00% ROISTROSutro Biopharma8/13/2026Lower Price Target$21.71$34.00Market Outperform$0.0000.00% ROIIOVAIovance Biotherapeutics8/7/2026Boost Price Target$6.12$8.00Market Outperform$0.0000.00% ROIONCBeOne Medicines8/6/2026Boost Price Target$327.53$405.00Market Outperform$0.0000.00% ROIONCBeOne Medicines7/1/2026Reiterated Rating$289.05$396.00Market Outperform$0.0000.00% ROILYELLyell Immunopharma6/15/2026Reiterated Rating$13.51$34.00Market Outperform$0.0000.00% ROIKURAKura Oncology6/15/2026Reiterated Rating$9.12$24.00Market Outperform$0.0000.00% ROICMPXCompass Therapeutics4/28/2026Reiterated Rating$1.97$10.00Market Outperform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. STROSutro Biopharma4/23/2026Boost Price Target$35.32$41.00Market Outperform$0.0000.00% ROISTROSutro Biopharma4/17/2026Boost Price Target$30.28$35.00Market Outperform$0.0000.00% ROIWHWKWhitehawk Therapeutics4/16/2026Initiated Coverage$3.90$8.00Market Outperform$0.0000.00% ROIALLOAllogene Therapeutics4/14/2026Boost Price Target$3.04$8.00Market Outperform$0.0000.00% ROIBCAXBicara Therapeutics3/31/2026Reiterated Rating$19.04$31.00Market Outperform$0.0000.00% ROIIMMXImmix Biopharma3/27/2026Reiterated Rating$9.02$23.00Market Outperform$0.0000.00% ROIIMMPPrima BioMed3/13/2026Downgrade$2.76Market Perform$0.0000.00% ROIPRLDPrelude Therapeutics3/11/2026Boost Price Target$3.60$6.00Market Outperform$0.0000.00% ROIIMMXImmix Biopharma3/9/2026Initiated Coverage$9.29$23.00Outperform$0.0000.00% ROILYELLyell Immunopharma3/9/2026Initiated Coverage$22.46$34.00Market Outperform$0.0000.00% ROIIOVAIovance Biotherapeutics3/3/2026Upgrade$3.79$5.00Market Outperform$0.0000.00% ROIIOVAIovance Biotherapeutics2/25/2026Upgrade$3.78$5.00Outperform$0.0000.00% ROIIMMPPrima BioMed2/23/2026Initiated Coverage$2.79$10.00Market Outperform$0.0000.00% ROIIMMPPrima BioMed2/17/2026Initiated Coverage$2.64$6.00Market Outperform$0.0000.00% ROISMMTSummit Therapeutics1/30/2026Reiterated Rating$15.40$40.00Market Outperform$0.0000.00% ROIBCAXBicara Therapeutics1/29/2026Initiated Coverage$16.59$31.00Market Perform$0.0000.00% ROISTROSutro Biopharma1/20/2026Upgrade$13.82$23.00Market Outperform$0.0000.00% ROIALLOAllogene Therapeutics1/9/2026Upgrade$1.49$5.00Outperform$0.0000.00% ROICMPXCompass Therapeutics12/3/2025Set Price Target$5.22$10.00$0.0000.00% ROICMPXCompass Therapeutics12/3/2025Initiated Coverage$5.22$10.00Market Outperform$0.0000.00% ROIZYMEZymeworks12/3/2025Initiated Coverage$25.10$32.00Market Outperform$0.0000.00% ROIONCBeOne Medicines11/7/2025Boost Price Target$332.36$396.00Market Outperform$0.0000.00% ROIBCYCBicycle Therapeutics10/31/2025Set Price Target$8.76$12.00$0.0000.00% ROIBCYCBicycle Therapeutics10/31/2025Boost Price Target$8.76$12.00Market Outperform$0.0000.00% ROISANASana Biotechnology10/30/2025Boost Price Target$5.37$8.00Market Outperform$0.0000.00% ROISMMTSummit Therapeutics10/20/2025Reiterated Rating$20.31$40.00Market Outperform$0.0000.00% ROIKURAKura Oncology10/20/2025Reiterated Rating$9.82$24.00Market Outperform$0.0000.00% ROISMMTSummit Therapeutics9/3/2025Reiterated Rating$24.15$40.00Market Outperform$00.0000.00% ROIINBXInhibrx Biosciences8/22/2025Reiterated Rating$24.16Market Perform$000.0000.00% ROIHOWLWerewolf Therapeutics8/21/2025Lower Price Target$1.24$3.00Market Outperform$0.0000.00% ROITrump’s “new Petrodollar” exposed (Ad)Trump has reportedly secured control over 65 billion barrels across 17 Venezuelan oil fields, more than the entire proven US reserve of 46 billion barrels. The deal includes a 35% government stake, guaranteed oil access, and century-long concessions, while pushing Chinese operators out of the region entirely. One analyst believes this is about more than oil. It could be the opening move in a dollar reset that hasn't happened since 1974.Watch the full investigation into Trump's new dollar strategy nowSMMTSummit Therapeutics8/19/2025Reiterated Rating$26.29$40.00Market Outperform$00.0000.00% ROIPRLDPrelude Therapeutics8/18/2025Lower Price Target$0.87$3.00Market Outperform$0.0000.00% ROIBCYCBicycle Therapeutics8/12/2025Lower Price Target$7.46$10.00Market Outperform$0.0000.00% ROIKURAKura Oncology8/11/2025Lower Price Target$5.54$24.00Market Outperform$0.0000.00% ROIALLOAllogene Therapeutics8/4/2025Reiterated Rating$1.19Market Perform$0.0000.00% ROISANASana Biotechnology6/24/2025Reiterated Rating$2.71$5.00Market Outperform$0.0000.00% ROIKURAKura Oncology6/4/2025Reiterated Rating$6.36$28.00Market Outperform$0.0000.00% ROITILInstil Bio6/2/2025Reiterated Rating$33.48Market Perform$0.0000.00% ROISMMTSummit Therapeutics6/2/2025Reiterated Rating$17.30$40.00Market Outperform$00.0000.00% ROILVTXLAVA Therapeutics5/15/2025Reiterated Rating$1.24Market Perform$0.0000.00% ROIINBXInhibrx Biosciences5/15/2025Reiterated Rating$11.84Market Perform$000.0000.00% ROIALLOAllogene Therapeutics5/14/2025Downgrade$1.13Market Perform$0.0000.00% ROIIOVAIovance Biotherapeutics5/9/2025Downgrade$3.17Market Perform$0.0000.00% ROIBCYCBicycle Therapeutics5/2/2025Lower Price Target$9.29$22.00Market Outperform$0.0000.00% ROIPRLDPrelude Therapeutics4/29/2025Reiterated Rating$0.90$4.00Market Outperform$0.0000.00% ROIKURAKura Oncology4/29/2025Reiterated Rating$6.51$28.00Market Outperform$0.0000.00% ROISMMTSummit Therapeutics4/28/2025Reiterated Rating$25.13$40.00Market Outperform$00.0000.00% ROISANASana Biotechnology3/18/2025Upgrade$2.77$5.00Outperform$0.0000.00% ROIALLOAllogene Therapeutics3/14/2025Upgrade$1.89$5.00Outperform$0.0000.00% ROISTROSutro Biopharma3/14/2025Downgrade$1.25Market Perform$00.0000.00% ROITILInstil Bio2/13/2025Reiterated Rating$20.88Market Perform$0.0000.00% ROIINCYIncyte2/11/2025Reiterated Rating$66.47Market Perform$000.0000.00% ROIACETAdicet Bio2/6/2025Reiterated Rating$1.03Market Perform$0.0000.00% ROIKURAKura Oncology2/6/2025Reiterated Rating$8.13$28.00Market Outperform$0.0000.00% ROIUBERUber Technologies2/6/2025Reiterated Rating$67.24Market Perform$00.0000.00% ROISTESTERIS2/6/2025Reiterated Rating$224.65$265.00Market Outperform$000.0000.00% ROIWUWestern Union2/6/2025Reiterated Rating$11.32Market Perform$00.0000.00% ROIWDAYWorkday2/6/2025Reiterated Rating$281.59$315.00Market Outperform$000.0000.00% ROIINBXInhibrx Biosciences1/22/2025Reiterated Rating$14.13Market Perform$00.0000.00% ROIINCYIncyte1/14/2025Reiterated Rating$72.37Market Perform$000.0000.00% ROIHOWLWerewolf Therapeutics1/14/2025Lower Price Target$1.35$4.00Market Outperform$0.0000.00% ROILVTXLAVA Therapeutics12/11/2024Downgrade$1.21Hold$0.0000.00% ROISANASana Biotechnology11/5/2024Downgrade$3.76Market Perform$0.0000.00% ROITILInstil Bio11/4/2024Initiated Coverage$28.78Market Perform$00.0000.00% ROISMMTSummit Therapeutics11/4/2024Initiated Coverage$18.99$32.00Market Outperform$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageCitigroupUBS GroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
